Quintiles to study uterine fibroid drugs; Novartis mulls $1.8B CMO sale;

> The Patient-Centered Outcomes Research Institute awarded Quintiles ($Q) a research grant to study the effectiveness of treatments for uterine fibroids. More

> ClinTec is boosting its presence in Russia, expanding operations in Moscow, St. Petersburg and Novosibirsk. Story

> Novartis ($NVS) and billionaire Dietmar Hopp are considering selling off their contract manufacturing joint venture, LTS Lohmann, for up to $1.83 billion. Article

> Contract Pharmaceutical Services of Australia received an FDA warning letter, citing GMP violations at a pharmaceutical packaging facility. Item

> NextPharma won a contract to provide packaging services for a Mitsubishi Pharma kidney disease drug. Report

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.